Company Filing History:
Years Active: 2021-2022
Title: Innovations by Inventor Anthony Chris Garland
Introduction
Anthony Chris Garland is a notable inventor based in Los Angeles, California. He has made significant contributions to the field of pharmaceuticals with a focus on innovative formulations. His work is characterized by his pursuit of advancements that benefit patients and the medical community.
Latest Patents
Garland holds two patents, which highlight his commitment to developing new pharmaceutical compositions. The first patent is related to the formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, alongside methods of making and using these formulations. This patent provides insights into compositions that include quantities of oltipraz crystals and describes methods for treating patients with these compositions.
The second patent further delves into similar formulations, focusing on taste-modified versions of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, again detailing methods of both creating and utilizing these compositions effectively. The provision of taste-modified compositions furthers the accessibility and acceptance of the drug among patients.
Career Highlights
Garland's career is marked by his role at St. IP Holding AG, where he continues to drive innovation in pharmaceutical applications. His dedication to research and development has not only expanded his personal portfolio of patents but also contributed to the company's reputation as a leader in the industry.
Collaborations
Throughout his career, Garland has collaborated with esteemed colleagues, including Barbara-Jean Anne Bormann-Kennedy and Bomi Framroze. These partnerships have enriched his research endeavors and have fostered a collaborative environment conducive to innovative breakthroughs in their field.
Conclusion
Anthony Chris Garland exemplifies the spirit of innovation in pharmaceuticals through his groundbreaking patents and collaborative efforts. His work not only showcases the importance of invention in medical science but also reflects a commitment to improving the quality of life for patients. As he continues to develop new formulations, the impact of his contributions is poised to grow even further.